Cytek Biosciences, Inc. CTKB Product — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s product — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s product — total revenue?
- Cytek Biosciences, Inc. (CTKB) reported product — total revenue of $1.44M in Q1 2026.
- How has Cytek Biosciences, Inc.'s product — total revenue changed year-over-year?
- Cytek Biosciences, Inc.'s product — total revenue increased by 46.4% year-over-year, from $983K to $1.44M.
- What is the long-term trend for Cytek Biosciences, Inc.'s product — total revenue?
- Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s product — total revenue has grown at a 103.4% compound annual growth rate (CAGR), from $664K to $5.59M.
- What does product — total revenue mean?
- This metric represents the gross total revenue recognized from the sale of products before any deductions for returns or allowances. It provides a comprehensive view of the top-line performance of the product business unit, reflecting the total volume of sales activity. This figure is essential for analyzing the overall market reach and revenue-generating capacity of the company's hardware and consumable offerings.